Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Nov
13
2015
Brazilian Patent and Trademark Office Publishes New Rule on Prioritization Examination of Patent Applications Michael Best & Friedrich LLP
Nov
30
2015
Biologics and Biosimilar Bits and Bytes – November 30, 2015 Michael Best & Friedrich LLP
Jan
8
2016
January 8, 2016 -- Biologics and Biosimilars Bits and Bytes Michael Best & Friedrich LLP
Jan
20
2014
BRIC-a-BRAC January 20, 2014: News Items from BRIC Countries Michael Best & Friedrich LLP
May
2
2016
U.S. Supreme Court Listens to Oral Arguments Regarding Claim Construction and Appellate Review of Institution Decisions in AIA Trials Michael Best & Friedrich LLP
Mar
12
2014
Settlement Does Not Guarantee Termination of IPR (Inter Partes Review) Proceedings Michael Best & Friedrich LLP
Jul
16
2014
The Thorny Problem of Patentable Eligible Subject Matter: Part 4 of a 10-Part Series: Russia Michael Best & Friedrich LLP
Nov
6
2016
New Requirements in Brazil for Plant Variety Protection Applications in View of Brazil’s Biodiversity Law Michael Best & Friedrich LLP
Jan
16
2017
Two Important Decisions Addressing ANVISA’s Prior Approval of Pharmaceutical Patents in Brazil Michael Best & Friedrich LLP
May
2
2017
Federal Circuit Rules That Public Sales Trigger the AIA On-Sale Bar Even If Claimed Features Are Not Publicly Disclosed Michael Best & Friedrich LLP
Dec
8
2014
The Breadth of India’s “Bolar Exemption” Michael Best & Friedrich LLP
Jan
29
2015
Post-Grant Review Offers Expanded Opportunity For Challenging American Invents Act (AIA) Patents Michael Best & Friedrich LLP
Dec
13
2010
USPTO Introduces Program that Allows Deferral of Patent Application Filing Fees Michael Best & Friedrich LLP
Jul
6
2011
Keeping Your Trademarks From Becoming XXX-Rated Michael Best & Friedrich LLP
Mar
11
2012
Social Media: Reap the Rewards While Avoiding the Pitfalls Michael Best & Friedrich LLP
Jul
21
2012
Patent Office Finalizes Rules on Preissuance Submissions by Third Parties Michael Best & Friedrich LLP
Oct
27
2012
Abandonment and Revival of U.S. Patent Application Michael Best & Friedrich LLP
Oct
14
2015
A Review of the Patent Related Provisions of the TPP – Patentable Subject Matter and Grace Periods Michael Best & Friedrich LLP
Mar
1
2013
Brand Owners Can Register Trademarks for Protection Mechanisms in New Generic Top-Level Domain (gTLDs) Michael Best & Friedrich LLP
Dec
14
2015
Merck’s Ezetrol and Patent Term Extension in Israel Michael Best & Friedrich LLP
May
19
2013
Prioritization of Examination of Patent Applications in Brazil for Pharmaceutical Products and Processes, and Devices and Equipment Related to Public Health Michael Best & Friedrich LLP
Aug
9
2013
Recent Decisions involving Section 3(d) of the Indian Patents Act Michael Best & Friedrich LLP
Feb
16
2016
Brazilian Patent Office and Patent Prosecution Highway Program Michael Best & Friedrich LLP
Sep
10
2013
Understanding Biologics and Biosimilars in Brazil Michael Best & Friedrich LLP
Mar
22
2016
Supreme Court Agrees to Review the Appropriate Measure of Design Patent Damages Michael Best & Friedrich LLP
Feb
24
2014
Patent Trolls: A View from Europe Michael Best & Friedrich LLP
May
6
2016
International Trade Commission Invalidates Patents to Fitness Monitoring Systems as Ineligible under § 101 Michael Best & Friedrich LLP
Jun
14
2016
Supreme Court Relaxes Standard for Enhancing Patent Damages in Halo Electronics, Inc. v. Pulse Electronics, Inc. Michael Best & Friedrich LLP
Jun
5
2014
Supreme Court Paves the Way for Invalidating Vague Patents Michael Best & Friedrich LLP
Jun
18
2014
Trademark Trial and Appeal Board Cancels Six REDSKINS Trademark Registrations Michael Best & Friedrich LLP
Dec
7
2016
Supreme Court Holds Profit from Components of Infringing Product Can Be Appropriate Measure of Design Patent Damages Michael Best & Friedrich LLP
Apr
10
2017
Brazil: Courts Confirm Preliminary Injunction Based on Pending Patent Applications Michael Best & Friedrich LLP
Jun
21
2017
Central District of California Analyzes Equitable Estoppel and Laches in View of Supreme Court’s Recent Laches Ruling Michael Best & Friedrich LLP
Feb
16
2015
Australia – A Further Update: The Thorny Problem of Patentable Eligible Subject Matter: Part 8 of a 10-Part Series Michael Best & Friedrich LLP
Apr
28
2015
Approval of First Biosimilar Monoclonal Antibody in Brazil Michael Best & Friedrich LLP
Sep
2
2012
Patent Reform – What You Need to Know for the Approaching September 16, 2012 Implementation Date Michael Best & Friedrich LLP
Nov
22
2015
Trans-Pacific Partnership and the Continuing Controversy Over the Exclusivity Period for Biologics Michael Best & Friedrich LLP
Dec
10
2015
Biologics and Biosimilars Bits and Bytes – December 10, 2015 Michael Best & Friedrich LLP
Jun
8
2013
Section 3(d) of the Indian Patents Act – Part I Michael Best & Friedrich LLP
Aug
29
2013
Section 8 of the Indian Patents Act and a Comparison with the Disclosure Requirements in Canada, Israel and the U.S. Michael Best & Friedrich LLP
Jan
15
2014
Time Period and Burden of Proof Requirements when Requesting Revocation of a Patent in Kenya Michael Best & Friedrich LLP
Jun
3
2016
An Overview of the USTR’s 2016 Special 301 Report on the State of IPR in Chile Michael Best & Friedrich LLP
Apr
10
2014
The Copaxone Story in the U.S. and India: A Further Update Michael Best & Friedrich LLP
Apr
23
2014
The Copaxone Story in the U.S. and India: To Stay or Not to Stay is the Question Michael Best & Friedrich LLP
Jun
30
2016
Overview of USTR’s 2016 Special 301 Report on State of Inter Partes Review in Argentina Michael Best & Friedrich LLP
Jul
13
2016
Federal Circuit Clarifies When an Invention is the Subject of a Commercial Sale or Offer for Sale for Purposes of the On-Sale Bar Michael Best & Friedrich LLP
Jun
20
2014
Availability of Biosimilar Pathways and Data/Marketing Exclusivity Globally: Update Michael Best & Friedrich LLP
Aug
28
2014
The Thorny Problem of Patentable Eligible Subject Matter: Part 8 of a 10-Part Series: Australia Michael Best & Friedrich LLP
Sep
22
2014
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 1 of a 5-Part Series Michael Best & Friedrich LLP
Oct
14
2014
First Mailbox Appeal to be decided by the Federal Court of Appeals in Brazil Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins